Home >> Company news >>Company news >> The first exhibition of Hopstem Bioengineering at 2017 International Biomedical Innovation Summit
Details

The first exhibition of Hopstem Bioengineering at 2017 International Biomedical Innovation Summit

    As a high-tech startup company in iPSCs disease modeling and drug screening platform area, Hopstem successfully held its first exhibition at the 2017 International Biomedical Innovation Summit. Besides showcases of our HopCell® products, we have also introduced our expertise in hiPSCs/hESCs differentiation, gene editing, cell banking and engineering, as well as new directions on cardio and liver cell differentiation. Our booth attracted a lot of attendees and many of them showed great interest with product inquiries and collaboration requests.

微信图片_20170929112533.jpg

    图片3.png

    图片4.png图片5.png




Technical Support: 森云科技 | Admin Login